Table 2 Putative identity of the significantly differentially expressed lipids between AD patients with and without severe OSA
From: Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
Putative identity | Class | Mass | RT (min) | Mass/z | Fold change | p |
|---|---|---|---|---|---|---|
LysoPC(18:0) | PL | 523.3624 | 3.63 | 524.3624 | 1.628 | 0.001 |
PC(40:6) | PL | 893.6143 | 7.40 | 892.6143 | 1.307 | 0.002 |
DG(40:3) | GL | 734.5885 | 9.16 | 733.5885 | 1.365 | 0.002 |
OxTG(62:12) | GL | 1059.885 | 9.98 | 1060.885 | 1.669 | 0.003 |
PE(P-40:6) | PL | 775.5565 | 7.63 | 776.5565 | 1.408 | 0.006 |
OxPC(42:9) | PL | 903.5824 | 6.56 | 904.5824 | 1.467 | 0.007 |
Cer(O-37:4)/OxCer(37:5) | SP | 587.4894 | 7.78 | 588.4894 | 0.753 | 0.012 |
PE(P-36:4) | PL | 723.5188 | 7.25 | 724.5188 | 1.259 | 0.013 |
OxTG(58:5) | GL | 1017.834 | 9.82 | 1018.834 | 1.358 | 0.019 |
LysoPC(16:0) | PL | 555.3516 | 2.74 | 554.3516 | 1.333 | 0.021 |
Cis-8,11,14,17-Eicosatetraenoic acid | FA | 364.2588 | 3.83 | 363.2588 | 1.402 | 0.024 |
PC(37:6) | PL | 791.5414 | 6.55 | 792.5414 | 0.671 | 0.024 |
TG(O-56:9) | GL | 924.7008 | 7.11 | 925.7008 | 1.339 | 0.024 |
PG(33:0) | PL | 737.5363 | 7.51 | 736.5363 | 1.418 | 0.025 |
PC(35:4) | PL | 749.5353 | 7.33 | 748.5353 | 1.32 | 0.027 |
TG(O-56:1) | GL | 902.8486 | 7.30 | 903.8486 | 0.74 | 0.028 |
LysoPC(18:1) | PL | 521.3469 | 2.89 | 522.3469 | 1.287 | 0.03 |
PS(42:2) | PL | 853.6181 | 7.39 | 852.6181 | 0.714 | 0.032 |
OxTG(58:6) | GL | 1015.822 | 9.66 | 1016.822 | 1.566 | 0.032 |
PE(P-36:1) | PL | 729.5663 | 8.11 | 728.5663 | 1.48 | 0.034 |
LysoPA(18:4) | PL | 430.2058 | 3.62 | 429.2058 | 1.481 | 0.036 |
OxAcCar(18:0) | FA | 443.3681 | 4.07 | 444.3681 | 0.715 | 0.037 |
TG(58:8) | GL | 990.7796 | 10.02 | 989.7796 | 1.454 | 0.04 |
9,10-Epoxyoctadecenoic acid | FA | 278.2241 | 2.62 | 277.2241 | 1.705 | 0.04 |
CL(78:2) | PL | 1605.186 | 7.56 | 1604.186 | 1.334 | 0.043 |